annual CAPEX:
$881.60M-$44.80M(-4.84%)Summary
- As of today (June 26, 2025), REGN annual capital expenditures is $881.60 million, with the most recent change of -$44.80 million (-4.84%) on December 31, 2024.
- During the last 3 years, REGN annual CAPEX has risen by +$329.70 million (+59.74%).
- REGN annual CAPEX is now -45.48% below its all-time high of $1.62 billion, reached on December 31, 2022.
Performance
REGN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$271.50M+$4.50M(+1.69%)Summary
- As of today (June 26, 2025), REGN quarterly capital expenditures is $271.50 million, with the most recent change of +$4.50 million (+1.69%) on March 31, 2025.
- Over the past year, REGN quarterly CAPEX has increased by +$109.70 million (+67.80%).
- REGN quarterly CAPEX is now -74.61% below its all-time high of $1.07 billion, reached on September 30, 2022.
Performance
REGN quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$991.30M+$109.70M(+12.44%)Summary
- As of today (June 26, 2025), REGN TTM capital expenditures is $991.30 million, with the most recent change of +$109.70 million (+12.44%) on March 31, 2025.
- Over the past year, REGN TTM CAPEX has increased by +$182.20 million (+22.52%).
- REGN TTM CAPEX is now -43.49% below its all-time high of $1.75 billion, reached on March 31, 2023.
Performance
REGN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
REGN CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.8% | +67.8% | +22.5% |
| 3 y3 years | +59.7% | +91.5% | +71.4% |
| 5 y5 years | +105.2% | +59.6% | +88.7% |
REGN CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.5% | +59.7% | -74.6% | +102.8% | -43.5% | +71.4% |
| 5 y | 5-year | -45.5% | +105.2% | -74.6% | +135.5% | -43.5% | +88.7% |
| alltime | all time | -45.5% | >+9999.0% | -74.6% | +644.1% | -43.5% | +2173.8% |
REGN CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $271.50M(+1.7%) | $991.30M(+12.4%) |
| Dec 2024 | $881.60M(-4.8%) | $267.00M(+10.4%) | $881.60M(-5.0%) |
| Sep 2024 | - | $241.90M(+14.7%) | $928.10M(+4.7%) |
| Jun 2024 | - | $210.90M(+30.3%) | $886.10M(+9.5%) |
| Mar 2024 | - | $161.80M(-48.4%) | $809.10M(-12.7%) |
| Dec 2023 | $926.40M(-42.7%) | $313.50M(+56.8%) | $926.40M(+7.1%) |
| Sep 2023 | - | $199.90M(+49.3%) | $865.10M(-50.1%) |
| Jun 2023 | - | $133.90M(-52.0%) | $1.73B(-1.1%) |
| Mar 2023 | - | $279.10M(+10.7%) | $1.75B(+8.5%) |
| Dec 2022 | $1.62B(+193.0%) | $252.20M(-76.4%) | $1.62B(+6.4%) |
| Sep 2022 | - | $1.07B(+596.2%) | $1.52B(+160.4%) |
| Jun 2022 | - | $153.60M(+8.3%) | $583.50M(+0.9%) |
| Mar 2022 | - | $141.80M(-8.5%) | $578.40M(+4.8%) |
| Dec 2021 | $551.90M(-10.2%) | $154.90M(+16.3%) | $551.90M(-1.2%) |
| Sep 2021 | - | $133.20M(-10.3%) | $558.40M(-3.5%) |
| Jun 2021 | - | $148.50M(+28.8%) | $578.40M(+3.3%) |
| Mar 2021 | - | $115.30M(-28.6%) | $559.80M(-8.9%) |
| Dec 2020 | $614.60M(+43.1%) | $161.40M(+5.4%) | $614.60M(+3.8%) |
| Sep 2020 | - | $153.20M(+17.9%) | $592.20M(+5.6%) |
| Jun 2020 | - | $129.90M(-23.6%) | $560.70M(+6.7%) |
| Mar 2020 | - | $170.10M(+22.4%) | $525.40M(+22.3%) |
| Dec 2019 | $429.60M(+12.1%) | $139.00M(+14.2%) | $429.60M(+14.2%) |
| Sep 2019 | - | $121.70M(+28.6%) | $376.10M(+4.3%) |
| Jun 2019 | - | $94.60M(+27.3%) | $360.60M(-4.6%) |
| Mar 2019 | - | $74.30M(-13.1%) | $378.00M(-1.3%) |
| Dec 2018 | $383.10M(+40.5%) | $85.50M(-19.5%) | $383.10M(-5.5%) |
| Sep 2018 | - | $106.20M(-5.2%) | $405.24M(+13.0%) |
| Jun 2018 | - | $112.00M(+41.1%) | $358.69M(+19.0%) |
| Mar 2018 | - | $79.40M(-26.2%) | $301.54M(+10.6%) |
| Dec 2017 | $272.60M(-46.7%) | $107.64M(+80.4%) | $272.60M(-13.6%) |
| Sep 2017 | - | $59.65M(+8.8%) | $315.38M(-15.7%) |
| Jun 2017 | - | $54.85M(+8.7%) | $374.28M(-18.3%) |
| Mar 2017 | - | $50.46M(-66.5%) | $458.27M(-10.5%) |
| Dec 2016 | $511.90M(-24.5%) | $150.41M(+26.9%) | $511.90M(-5.1%) |
| Sep 2016 | - | $118.56M(-14.6%) | $539.26M(-4.9%) |
| Jun 2016 | - | $138.84M(+33.4%) | $566.81M(-15.1%) |
| Mar 2016 | - | $104.09M(-41.4%) | $667.87M(-1.5%) |
| Dec 2015 | $677.93M(+103.6%) | $177.78M(+21.7%) | $677.93M(+9.8%) |
| Sep 2015 | - | $146.10M(-39.1%) | $617.70M(+12.0%) |
| Jun 2015 | - | $239.89M(+110.1%) | $551.37M(+44.2%) |
| Mar 2015 | - | $114.16M(-2.9%) | $382.35M(+14.8%) |
| Dec 2014 | $333.01M(+113.0%) | $117.54M(+47.4%) | $333.01M(+17.1%) |
| Sep 2014 | - | $79.77M(+12.6%) | $284.44M(+20.3%) |
| Jun 2014 | - | $70.87M(+9.3%) | $236.36M(+18.2%) |
| Mar 2014 | - | $64.82M(-6.0%) | $199.94M(+27.9%) |
| Dec 2013 | $156.32M(+216.8%) | $68.98M(+117.7%) | $156.32M(+52.5%) |
| Sep 2013 | - | $31.69M(-8.0%) | $102.51M(+26.5%) |
| Jun 2013 | - | $34.45M(+62.5%) | $81.07M(+36.3%) |
| Mar 2013 | - | $21.20M(+39.8%) | $59.48M(+20.6%) |
| Dec 2012 | $49.34M(-13.8%) | $15.16M(+48.0%) | $49.34M(+8.5%) |
| Sep 2012 | - | $10.25M(-20.4%) | $45.46M(+3.1%) |
| Jun 2012 | - | $12.87M(+16.4%) | $44.11M(-4.3%) |
| Mar 2012 | - | $11.05M(-2.1%) | $46.11M(-19.4%) |
| Dec 2011 | $57.22M(-42.6%) | $11.29M(+26.9%) | $57.22M(-26.8%) |
| Sep 2011 | - | $8.90M(-40.1%) | $78.19M(-14.4%) |
| Jun 2011 | - | $14.86M(-32.9%) | $91.39M(-7.8%) |
| Mar 2011 | - | $22.17M(-31.3%) | $99.11M(-0.6%) |
| Dec 2010 | $99.69M(+2.4%) | $32.26M(+46.0%) | $99.69M(+11.1%) |
| Sep 2010 | - | $22.10M(-2.1%) | $89.74M(-0.3%) |
| Jun 2010 | - | $22.58M(-0.7%) | $89.97M(-8.3%) |
| Mar 2010 | - | $22.74M(+1.9%) | $98.14M(+0.8%) |
| Dec 2009 | $97.32M(+179.2%) | $22.32M(-0.1%) | $97.32M(+7.2%) |
| Sep 2009 | - | $22.33M(-27.4%) | $90.74M(+16.7%) |
| Jun 2009 | - | $30.75M(+40.3%) | $77.74M(+44.7%) |
| Mar 2009 | - | $21.92M(+39.2%) | $53.73M(+54.1%) |
| Dec 2008 | $34.86M | $15.74M(+68.7%) | $34.86M(+16.8%) |
| Sep 2008 | - | $9.33M(+38.4%) | $29.85M(+18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $6.74M(+121.3%) | $25.21M(+24.2%) |
| Mar 2008 | - | $3.05M(-71.6%) | $20.30M(+10.0%) |
| Dec 2007 | $18.45M(+556.2%) | $10.73M(+128.7%) | $18.45M(+106.7%) |
| Sep 2007 | - | $4.69M(+156.8%) | $8.92M(+84.0%) |
| Jun 2007 | - | $1.83M(+52.6%) | $4.85M(+44.2%) |
| Mar 2007 | - | $1.20M(-0.9%) | $3.36M(+19.6%) |
| Dec 2006 | $2.81M(-43.4%) | $1.21M(+95.8%) | $2.81M(+43.9%) |
| Sep 2006 | - | $617.00K(+81.5%) | $1.95M(-36.0%) |
| Jun 2006 | - | $340.00K(-47.4%) | $3.05M(-28.2%) |
| Mar 2006 | - | $646.00K(+84.0%) | $4.25M(-14.4%) |
| Dec 2005 | $4.96M(-19.6%) | $351.00K(-79.5%) | $4.96M(-16.4%) |
| Sep 2005 | - | $1.72M(+11.6%) | $5.94M(-9.1%) |
| Jun 2005 | - | $1.54M(+13.2%) | $6.54M(-0.2%) |
| Mar 2005 | - | $1.36M(+2.4%) | $6.55M(+6.1%) |
| Dec 2004 | $6.17M(-79.2%) | $1.33M(-42.7%) | $6.17M(+0.7%) |
| Sep 2004 | - | $2.31M(+49.5%) | $6.13M(-14.9%) |
| Jun 2004 | - | $1.55M(+57.2%) | $7.20M(-32.3%) |
| Mar 2004 | - | $985.00K(-23.3%) | $10.64M(-64.1%) |
| Dec 2003 | $29.66M(-13.7%) | $1.28M(-62.0%) | $29.66M(-31.9%) |
| Sep 2003 | - | $3.39M(-32.0%) | $43.54M(-10.2%) |
| Jun 2003 | - | $4.98M(-75.1%) | $48.47M(-3.8%) |
| Mar 2003 | - | $20.00M(+31.9%) | $50.37M(+46.6%) |
| Dec 2002 | $34.37M(+318.0%) | $15.17M(+82.4%) | $34.37M(+57.7%) |
| Sep 2002 | - | $8.32M(+20.9%) | $21.80M(+43.0%) |
| Jun 2002 | - | $6.88M(+72.0%) | $15.25M(+44.1%) |
| Mar 2002 | - | $4.00M(+53.8%) | $10.58M(+28.7%) |
| Dec 2001 | $8.22M(+26.6%) | $2.60M(+47.1%) | $8.22M(+21.1%) |
| Sep 2001 | - | $1.77M(-20.2%) | $6.79M(+12.0%) |
| Jun 2001 | - | $2.21M(+34.7%) | $6.06M(-4.8%) |
| Mar 2001 | - | $1.64M(+41.0%) | $6.37M(-2.0%) |
| Dec 2000 | $6.50M(+13.9%) | $1.17M(+11.9%) | $6.50M(+6.0%) |
| Sep 2000 | - | $1.04M(-58.7%) | $6.13M(-2.5%) |
| Jun 2000 | - | $2.52M(+42.2%) | $6.29M(-2.8%) |
| Mar 2000 | - | $1.77M(+121.4%) | $6.47M(+13.5%) |
| Dec 1999 | $5.70M(+90.0%) | $800.00K(-33.3%) | $5.70M(+3.6%) |
| Sep 1999 | - | $1.20M(-55.6%) | $5.50M(-1.8%) |
| Jun 1999 | - | $2.70M(+170.0%) | $5.60M(+80.6%) |
| Mar 1999 | - | $1.00M(+66.7%) | $3.10M(+3.3%) |
| Dec 1998 | $3.00M(+42.9%) | $600.00K(-53.8%) | $3.00M(0.0%) |
| Sep 1998 | - | $1.30M(+550.0%) | $3.00M(+42.9%) |
| Jun 1998 | - | $200.00K(-77.8%) | $2.10M(+16.7%) |
| Mar 1998 | - | $900.00K(+50.0%) | $1.80M(-14.3%) |
| Dec 1997 | $2.10M(-75.6%) | $600.00K(+50.0%) | $2.10M(0.0%) |
| Sep 1997 | - | $400.00K(-500.0%) | $2.10M(-4.5%) |
| Jun 1997 | - | -$100.00K(-108.3%) | $2.20M(-56.0%) |
| Mar 1997 | - | $1.20M(+100.0%) | $5.00M(-41.9%) |
| Dec 1996 | $8.60M(+160.6%) | $600.00K(+20.0%) | $8.60M(-19.6%) |
| Sep 1996 | - | $500.00K(-81.5%) | $10.70M(+0.9%) |
| Jun 1996 | - | $2.70M(-43.8%) | $10.60M(+32.5%) |
| Mar 1996 | - | $4.80M(+77.8%) | $8.00M(+142.4%) |
| Dec 1995 | $3.30M(-52.2%) | $2.70M(+575.0%) | $3.30M(+3200.0%) |
| Sep 1995 | - | $400.00K(+300.0%) | $100.00K(-75.0%) |
| Jun 1995 | - | $100.00K(0.0%) | $400.00K(-73.3%) |
| Mar 1995 | - | $100.00K(-120.0%) | $1.50M(-78.3%) |
| Dec 1994 | $6.90M(-32.4%) | -$500.00K(-171.4%) | $6.90M(-55.5%) |
| Sep 1994 | - | $700.00K(-41.7%) | $15.50M(-3.1%) |
| Jun 1994 | - | $1.20M(-78.2%) | $16.00M(+3.2%) |
| Mar 1994 | - | $5.50M(-32.1%) | $15.50M(+52.0%) |
| Dec 1993 | $10.20M(+385.7%) | $8.10M(+575.0%) | $10.20M(-121.3%) |
| Sep 1993 | - | $1.20M(+71.4%) | -$47.80M(-2755.6%) |
| Jun 1993 | - | $700.00K(+250.0%) | $1.80M(0.0%) |
| Mar 1993 | - | $200.00K(-100.4%) | $1.80M(-14.3%) |
| Dec 1992 | $2.10M(+110.0%) | -$49.90M(-198.2%) | $2.10M(-96.0%) |
| Sep 1992 | - | $50.80M(+7157.1%) | $52.00M(+4233.3%) |
| Jun 1992 | - | $700.00K(+40.0%) | $1.20M(+140.0%) |
| Mar 1992 | - | $500.00K | $500.00K |
| Dec 1991 | $1.00M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual CAPEX year-on-year change?
- What is Regeneron Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Regeneron Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM CAPEX year-on-year change?
What is Regeneron Pharmaceuticals annual capital expenditures?
The current annual CAPEX of REGN is $881.60M
What is the all time high annual CAPEX for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual capital expenditures is $1.62B
What is Regeneron Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, REGN annual capital expenditures has changed by -$44.80M (-4.84%)
What is Regeneron Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of REGN is $271.50M
What is the all time high quarterly CAPEX for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly capital expenditures is $1.07B
What is Regeneron Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, REGN quarterly capital expenditures has changed by +$109.70M (+67.80%)
What is Regeneron Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of REGN is $991.30M
What is the all time high TTM CAPEX for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM capital expenditures is $1.75B
What is Regeneron Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, REGN TTM capital expenditures has changed by +$182.20M (+22.52%)